Home Investment Commentary Rio Tinto hikes dividend by 70%, GlaxoSmithKline holds dividend steady

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy